Biogen Inc. buy Cantor Fitzgerald
Start price
20.02.24
/
50%
€200.60
Target price
20.02.25
€287.58
Performance (%)
-35.17%
End price
21.02.25
€130.05
Summary
This prediction ended on 21.02.25 with a price of €130.05. The BUY prediction by Cantor_Fitzgerald for Biogen Inc. performed very badly with a performance of -35.17%. Cantor_Fitzgerald has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 8.456% | 8.456% | 76.007% |
| iShares Core DAX® | -1.358% | -2.165% | 2.078% |
| iShares Nasdaq 100 | -3.700% | -1.162% | 32.596% |
| iShares Nikkei 225® | -2.512% | 7.930% | 58.269% |
| iShares S&P 500 | -1.662% | -0.698% | 22.962% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten